1.Development progress and application of monoclonal antibody drugs against respiratory virus
ZHOU Jian⁃hua ; YUE Xin ; PAN Yong⁃bing
Chinese Journal of Biologicals 2023;36(1):89-97
Abstract:In recent years,the outbreak and prevalence of respiratory infectious diseases in the world seriously endanger
human health,among which the respiratory infectious diseases caused by viral infection account for a large proportion. The
use of vaccines and common antiviral drugs is an effective way to fight viral infection,but there are also problems such as lag
and drug resistance. Monoclonal antibodies against respiratory viral infections provide a new strategy for clinical
treatment. This paper reviews the development of monoclonal antibody against respiratory virus and its application in
respiratory viral infectious diseases.
Keywords:Respiratory viral infectious diseases;Respiratory syncytial virus(RSV);Influenza virus(IFV);Coronavirus
(CoV);Monoclonal antibody
2.In vitro Antiviral activity of a berberine derivant HB-13 against herpes simplex virus
Jian-Bing WU ; Xin-Yu LI ; Lin LIN ; Pan-Gen CUI ; Jia-Run ZHENG ;
Chinese Journal of Dermatology 2003;0(11):-
Objective To evaluate the in vitro antiviral activity of HB-13,a compound derivant from berberine and its prodrug berberine,against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). Methods Vero cells were cultured in vitro and infected with HSV.Then,various concentrations of HB-13, berberine,and aciclovir were used to treat these infected cells.The cytopathic effect was observed to deter- mine the antiviral effects and cytotoxicity of HB-13 and berberine.Results For HB-13,berberine and acy- clovir,the half toxicity concentration (TC_(50)) to Vero cells was 31.99,380 and more than 800?g/mL, respectively;the average half inhibitory concentration (IC_(50)) against HSV-1 was 1.328,more than 100,and 0.443?g/mL,respectively,the treatment index (TI) against HSV-1 was 24.09,less than 3.80,and more than 1805.87,respectively;the IC_(50) against HSV-2 was 1.344,more than 100,and 0.679?g/mL,respectively,the TI against HSV-2 was 23.80,less than 3.80 and more than 1178.20,respectively.Conclusion HB-13 possesses marked antiviral activity against HSV-1 and HSV-2 in vitro,while berberine does not.
3.Establishment of a scoring system for predicting the positive rate of prostatic biopsy for prostate cancer.
Jian-gang CHEN ; Xin-feng CHEN ; Dong-hua GU ; Ming LU ; Bing ZHENG ; Bing ZHANG ; Bin PAN ; Hua ZHU ; Xiao-dong PAN ; Bin XU ; Lin QIAN
National Journal of Andrology 2015;21(1):53-56
OBJECTIVETo identify the predictors of the positive results of transrectal ultrasound (TRUS)-guided biopsy for prostate cancer.
METHODSWe performed univariate and multivariate logistic regression analyses on the relevant data on 385 male patients that underwent TRUS-guided biopsy for prostate cancer, including such potential predictors as age, body mass index (BMI), symptoms, results of digital rectal examination (DRE), tPSA, fPSA, free/total PSA ratio (f/tPSA), prostate volume (PV), and PSA density (PSAD) for identification of the risk factors related to the positive rate of biopsy. Then we constructed a scoring system as a tool for predicting prostate cancer in repeat biopsies and determined the sensitivity of the system by calculating the false positive rate using the receiver operating characteristic curve.
RESULTSAmong the 385 patients, 139 (36.1%) were diagnosed with prostate cancer. On multivariate analysis, age (P < 0.01), DRE (P < 0.01), tPSA (P < 0.01), fPSA (P < 0.01), f/tPSA (P < 0.01), PV (P < 0.01), and PSAD (P < 0.01) were all significant predictors of prostate cancer. Multivariate logistic regression analysis showed age, tPSA, f/tPSA, PV, and PSAD to be independent predictors, with ORs and 95% CIs of 1.07 (1.05-1.16), 1.05 (1.02-1.15), 0.97 (0.86-0.99), 0.98 (0.87-0.96), and 1.79 (1.48-2.06), respectively. Moreover, patients with the risk score of 3-5 had a significantly higher rate of prostate cancer than those with 0-2 (64% vs 11%, P < 0.001).
CONCLUSIONThe scoring system on the key predictors of prostate cancer can help urologists to identify the men in need of prostatic biopsy.
Aged ; Digital Rectal Examination ; Humans ; Image-Guided Biopsy ; methods ; Logistic Models ; Male ; Middle Aged ; Prostate ; pathology ; Prostate-Specific Antigen ; analysis ; Prostatic Neoplasms ; chemistry ; pathology ; ROC Curve ; Risk Factors ; Ultrasonography, Interventional ; methods
4.KCNE2 modulates the function of Kv4.3 channel.
Jie LIU ; Jian-xin DENG ; Bing-xing PAN ; Qiao-bing HUANG
Journal of Southern Medical University 2006;26(12):1754-1756
OBJECTIVETo understand the role of KCNE2 in functional regulation of Kv4.3, the major alpha subunit of transient outward current (I(to)) in human heart.
METHODSThe cDNAs of Kv4.3 or Kv4.3 plus KCNE2 were transfected into COS-7 cells and 24-36 h after the transfection, the channel proteins were expressed in the surface membrane of the cells and the channel currents were recorded with patch-clamp technique in whole-cell mode.
RESULTSKCNE2 played an important role in modulating the channel function. The recorded current density was decreased in cells co-expressing KCNE2 and Kv4.3 to 152.96-/+33.71 pA/pF (n=16) as compared with Kv4.3-expressing cells with a mean current density of 375.13-/+112.87 pA/pF (n=11). At the recording voltage of 60 mV, KCNE2 increased the time to peak (TTP) of the current. TTP in only Kv4.3-expressing cells was 4.82-/+0.32 ms (n=11), significantly shorter than the TTP of 20.41-/+2.13 ms (n=16) in cells co-expressing Kv4.3 and KCNE2 (P<0.05). In the presence of KCNE2, the voltage-dependent inactivation of Kv4.3 showed a positive shift. The voltage of half maximum inactivation (V(0.5)) was decreased significantly from -53.62-/+1.24 mV (n=8) in Kv4.3 group to -46.58-/+1.6 mV (n=10) in KCNE2 co-expression group (P<0.05). KCNE2 accelerated the recovery of the channel from inactivation, reducing the recovery time constant (tau) from 193.43-/+17.98 ms to 137.71-/+18.29 ms.
CONCLUSIONKCNE2 might serve as an important beta subunit and play a role in the regulation of I(to) function in human heart.
Animals ; COS Cells ; Cercopithecus aethiops ; Humans ; Kv Channel-Interacting Proteins ; genetics ; metabolism ; Membrane Potentials ; physiology ; Patch-Clamp Techniques ; Potassium Channels, Voltage-Gated ; genetics ; metabolism ; physiology ; Shal Potassium Channels ; genetics ; metabolism ; physiology ; Transfection
5.Surgical management and preservation of laryngeal function for senile patients with advanced laryngeal carcinoma.
Dao-gong ZHANG ; Han-bing ZHANG ; Xin-yong LUAN ; Xin-liang PAN ; Guang XIE
Chinese Journal of Oncology 2007;29(5):379-381
OBJECTIVETo explore the methods of surgical treatment and preservation of laryngeal function in senile patients with advanced laryngeal carcinoma.
METHODSA retrospective data review of 87 advanced laryngeal carcinoma patients aged over 65 years was carried out. Of these 87 patients treated by different modes of surgery, 48 had supraglottic cancer, 35 glottic cancer and 4 subglottic cancer. The surgery modes consisted of major partial laryngectomy in 36 patients, subtotal partial laryngectomy with laryngoplasty in 21 and total laryngectomy in 30. All patients received postoperative radiotherapy to a dose of 50-60 Gy. Kaplan-Meier method was used to analyze the survival.
RESULTSThe overall 3- and 5-year survival rate was 73.2% and 67.4%, respectively. The ultimate rate of larynx preservation was 65.5%. Of 57 patients with partial laryngectomy, 46 were decannulated with a decannulation rate of 80.7%. Yet, in all patients, the nasal feeding tube was removed and food intake per os was resumed. All patients who underwent partial laryngectomy regained their phonation function.
CONCLUSIONIt is safe and effective to treat and preserve laryngeal function surgically in the senile patients with advanced laryngeal carcinoma. The key points to achieve this are selection of proper patient, renovation of surgical procedure and improvement of surgical skill.
Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell ; pathology ; radiotherapy ; surgery ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Laryngeal Neoplasms ; pathology ; radiotherapy ; surgery ; Laryngectomy ; methods ; Larynx ; pathology ; surgery ; Lymphatic Metastasis ; Male ; Neck Dissection ; methods ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Postoperative Period ; Radiotherapy, Adjuvant ; Retrospective Studies
7.Analysis of the accidents of acute occupational poisoning from 1994 to 2003 in Beijing.
Ru-gang WANG ; Shao-ying BAI ; Bing-xun KAO ; Xing GAO ; Yong-xian TAO ; He-xin ZHENG ; Zi-he HUANG ; Xue-jing SUN ; Li-qun PAN
Chinese Journal of Industrial Hygiene and Occupational Diseases 2005;23(4):297-298
8.Polycomb group proteins and their roles in regulating stem cell development.
Bing-yang HUANG ; Xiao-yan PAN ; Zhi-xin LI ; Zheng-chao WANG ; Yong-sheng YU ; Zhao-hua DOU
Acta Academiae Medicinae Sinicae 2012;34(3):281-285
Polycomb group (PcG) proteins are a family of epigenetic regulators responsible for the repression of genes in proliferation and differentiation of stem cells. PcG protein complex consists of two important epigenetic regulators: PRC1 (polycomb repressive complex 1) and PRC2 (polycomb repressive complex 2). In order to further understand the functions of PcG proteins in stem cell growth and differentiation, we review the PcG protein composition, PcG protein localization in the target gene, PcG protein recruitment, and the functions of PcG proteins in the development of stem cells.
Cell Differentiation
;
physiology
;
Cell Proliferation
;
Humans
;
Polycomb Repressive Complex 1
;
metabolism
;
physiology
;
Polycomb Repressive Complex 2
;
metabolism
;
physiology
;
Polycomb-Group Proteins
;
metabolism
;
physiology
;
Stem Cells
;
cytology
;
metabolism
9.The metastasis suppressing ability and its mechanism of calmodulin antagonist EBB in human metastatic ovarian clear cell line ES-2
Rui HUANG ; Linlin JIANG ; Xiaoming SUN ; Yuan ZHOU ; Xin CHENG ; Ming YANG ; Yuanfu XU ; Dongsheng XIONG ; Caiyun WANG ; Chunzheng YANG ; Bing PAN ; Huifang ZHU
Chinese Pharmacological Bulletin 1986;0(05):-
Aim To investigate the potential suppressing effect of calmodulin antagonist EBB on metastasis-associated properties of human metastatic ovarian clear cell adenocarcinoma cell ES-2.Methods MTT assay was used to assess the growth inhibition of EBB on ES-2 cells.The invasive capacity and motility potential were determined by Transwell chamber assay and Wound assay.[Ca2+]i was observed under the laser scanning confocal microscopy.Results EBB inhibited the proliferation of ES-2 cells in vitro.The IC50 on ES-2 cells was(13.67?1.56)?mol?L-1.The invasive ability and motility potential of ES-2 cells were decreased after exposure to 3,7 and 14 ?mol?L-1 EBB respectively(P